Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL23AP1 is a **processed pseudogene** related to the ribosomal protein L23a gene (RPL23A). It does not encode a functional protein and has no direct role in ribosome structure or protein synthesis. Pseudogenes like RPL23AP1 are typically remnants of gene duplication and retrotransposition events and may be transcribed as non-coding RNAs, but generally lack a clear biological function[8][3]. Some ribosomal protein pseudogenes in other contexts have been implicated in regulatory processes or cancer biology, but no such evidence exists for RPL23AP1. There are more than 90 RPL23A-related pseudogenes cataloged in the human genome[1]. The true protein-coding gene, ribosomal protein L23a (RPL23A), is important for the structural integrity of the large ribosomal subunit and protein synthesis; RPL23AP1 should not be confused with the functional gene or its protein product[1][4].
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 1 (RPL23AP1).